Cargando…
TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
A novel, highly selective biomarker is urgently needed to predict and monitor triple-negative breast cancer (TNBC) because targeting molecules are not currently available. Although associated with various malignant tumors, the role of toll-like receptor 5 (TLR5) in TNBC remains uncertain. We aimed t...
Autores principales: | Shi, Dai, Zhao, Shanshan, Jiang, Wen, Zhang, Chao, Liang, Ting, Hou, Guihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920449/ https://www.ncbi.nlm.nih.gov/pubmed/31852883 http://dx.doi.org/10.1038/s41419-019-2187-8 |
Ejemplares similares
-
TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining
por: Shi, Dai, et al.
Publicado: (2019) -
Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast Cancer (TNBC) Based on Radionuclide Imaging
por: Jiang, Wen, et al.
Publicado: (2021) -
Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer
por: Wei, Wei, et al.
Publicado: (2020) -
T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019) -
IL‐27 Rα(+) cells promoted allorejection via enhancing STAT1/3/5 phosphorylation
por: Zhao, Shanshan, et al.
Publicado: (2020)